Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc VIVXF

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


GREY:VIVXF - Post by User

Bullboard Posts
Comment by Rugger1on Mar 30, 2015 10:21am
102 Views
Post# 23576362

RE:Let's talk about Antibiotics for a minute!

RE:Let's talk about Antibiotics for a minute!We do know that the product is being used on Tilapia in Thailand by Nam Sai Farms.  This was a trial that started in the summer of last year and we should see if the product will be used further in the comming quarters.  An excerpt of the trial itself is found here.

"The trial is entitled "Commercial investigation into the effects of OxC-beta dietary addition on performance of red tilapia grown out in cages." It will test the effects of two different levels of OxC-beta and a positive control product against a negative control on the grow-out parameters of tilapia raised in cages in an earthen reservoir. Five replicates of each treatment group will be conducted, for a total of 20 groups of 300 fish each. The grow-out period is expected to take approximately six months to complete, following which a final study report will be prepared."
Bullboard Posts